Patients
| Country | Value | Year |
|---|---|---|
| France | 16.5 | 2023 |
| Germany | 13.1 | 2023 |
| Italy | 7.2 | 2023 |
| Russia | 21.8 | 2023 |
| Spain | 8.6 | 2023 |
| UK | 10.1 | 2023 |
Updated
Reviewed by Vidhi Upadhyay
Europe Stress Relief Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$601.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $740.0 Mn | — | — |
| 2025 (base) | $788.1 Mn | +$48.1 Mn | — |
| 2026 (forecast) | $839.3 Mn | +$51.2 Mn | +6.5% |
| 2027 (forecast) | $893.8 Mn | +$54.6 Mn | +13.4% |
| 2028 (forecast) | $951.9 Mn | +$58.1 Mn | +20.8% |
| 2029 (forecast) | $1.01 Bn | +$61.9 Mn | +28.6% |
| 2030 (forecast) | $1.08 Bn | +$65.9 Mn | +37% |
| 2031 (forecast) | $1.15 Bn | +$70.2 Mn | +45.9% |
| 2032 (forecast) | $1.22 Bn | +$74.7 Mn | +55.4% |
| 2033 (forecast) | $1.30 Bn | +$79.6 Mn | +65.5% |
| 2034 (forecast) | $1.39 Bn | +$84.8 Mn | +76.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $788.1 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.39 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.5% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Ingredient, form and distribution channel (see all) |
| Key players | Olly (Unilever), Natrol LLC, Nature’s Bounty, Goli Nutrition, Himalaya Wellness (see all) |
| Regulator in Europe | EMA and EFSASource: European Medicines Agency. Checked 14 Nov 2026.Source: European Food Safety Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Stress relief supplements contain ingredients such as ashwagandha, magnesium, L-theanine and herbal blends marketed to ease stress and support calm.
Key segments of the stress Relief Supplements market include ingredient (Ashwagandha, Magnesium and L-Theanine) and form (Capsules, Gummies and Powders).
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the stress Relief Supplements market. Governments and employers are investing more in mental health care.
Digital tools, new drug classes and care built into primary care and workplaces give the stress Relief Supplements market strong room to grow worldwide.
Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the stress Relief Supplements market.
The stress Relief Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the EU, many new medicines are authorised once for every member state by the European Commission, after review by the European Medicines Agency (EMA).[1] In the countries we cover here, medicines are approved by ANSM (France)[2], BfArM (Germany)[3], AIFA (Italy)[4], Ministry of Health (Russia)[5], AEMPS (Spain)[6] and MHRA (UK)[7]. EU law sets common rules for food supplements, and the European Food Safety Authority (EFSA) assesses their health claims.[8] In the countries we cover here, supplement rules come from DGCCRF and ANSES (France)[9], BVL (Germany)[10], Ministry of Health (Italy)[11], Rospotrebnadzor (Russia)[12], AESAN (Spain)[13] and FSA (UK)[14].
[1] European Medicines Agency. Checked 14 Nov 2026.
[2] ANSM, French medicines agency. Checked 14 Nov 2026.
[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
[4] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
[5] Ministry of Health of the Russian Federation. Checked 14 Nov 2026.
[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[8] European Food Safety Authority. Checked 14 Nov 2026.
[9] ANSES. Checked 14 Nov 2026.
[10] Federal Office of Consumer Protection and Food Safety (BVL). Checked 14 Nov 2026.
[11] Italian Ministry of Health. Checked 14 Nov 2026.
[12] Rospotrebnadzor. Checked 14 Nov 2026.
[13] Spanish Agency for Food Safety and Nutrition (AESAN). Checked 14 Nov 2026.
[14] Food Standards Agency. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern stress Relief Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Europe.
What doctors and scientists are doing in Stress Relief Supplements right now, from free public sources.
| Country | Value | Year |
|---|---|---|
| France | 16.5 | 2023 |
| Germany | 13.1 | 2023 |
| Italy | 7.2 | 2023 |
| Russia | 21.8 | 2023 |
| Spain | 8.6 | 2023 |
| UK | 10.1 | 2023 |
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe · 5 shared keywords
Europe · 5 shared keywords
Europe · 4 shared keywords
Europe · 4 shared keywords
Europe · 4 shared keywords
Europe · 4 shared keywords
Pharmaceuticals · Europe
Digital Health · Europe
Digital Health · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe
Healthcare Services · Europe